Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
Discovery and validation of extracellular vesicle-associated miRNAs as noninvasive detection biomarkers for early-stage non-small-cell lung cancer.
复制标题
细胞外囊泡相关 miRNA 作为早期非小细胞肺癌无创检测生物标志物的发现和验证。
DOI：
10.1002/1878-0261.12889
复制
发表时间：
2021-09
影响因子：
6.6
通讯作者：
Wang C
中科院分区：
文献类型：
--
作者：
Zhong Y;Ding X;Bian Y;Wang J;Zhou W;Wang X;Li P;Shen Y;Wang JJ;Li J;Zhang C;Wang C
miRNAs in circulating extracellular vesicles (EVs) are promising biomarkers for cancer. However, their diagnostic ability for early‐stage non‐small‐cell lung cancer (NSCLC) is not well known. In this study, the circulating EV miRNAs profiling was initially performed in 36 untreated NSCLC patients and 36 healthy controls by TaqMan Low Density Array (TLDA). Subsequently, we performed quantitative reverse‐transcription PCR assay (RT‐qPCR) validation in several independent cohorts that included 159 NSCLC patients, 120 age/sex‐matched healthy controls and 31 benign nodule patients enrolled from three different clinical centres. In addition, 38 cases of NSCLC were analysed before and after surgery. We demonstrated that miR‐520c‐3p and miR‐1274b were significantly and steadily increased in NSCLC patients in comparison with healthy controls and benign nodule patients (P < 0.001) and decreased markedly after tumour resection (P < 0.001). The areas under the curve (AUCs) of the ROC curve of the two‐miRNA panel were 0.857 (95% CI, 0813–0.901; P < 0.0001) and 0.845 (95% CI, 0.793–0.896; P < 0.0001) for NSCLC and NSCLC stage I, respectively. Furthermore, the panel was able to differentiate NSCLC from benign nodules with an AUC of 0.823 (95% CI, 0.730–0.915; P < 0.0001). Furthermore, logistic regression analysis revealed the two‐miRNA panel as an independent risk factor for NSCLC (OR = 16.128, P < 0.0001). In conclusion, miR‐520c‐3p and miR‐1274b have biomarker potential for early diagnosis of NSCLC in multiple centres. Sensitive and specific biomarkers for the detection of non‐small‐cell lung cancer (NSCLC) are urgently needed. Here, we investigated the diagnostic potential of extracellular vesicle (EV) miRNAs as biomarkers for NSCLC in a multiphase case–control study. We report that EV‐miR‐520c‐3p and miR‐1274b hold potential as novel diagnostic biomarkers for early‐stage NSCLC.
登录
查看更多内容
影响因子：
56.9
作者：
Lagos-Quintana, M;Rauhut, R;Tuschl, T
通讯作者：
Tuschl, T
循环外泌体 microRNA 作为非小细胞肺癌的预后生物标志物
影响因子：
--
作者：
Liu Q;Yu Z;Yuan S;Xie W;Li C;Hu Z;Xiang Y;Wu N;Wu L;Bai L;Li Y
通讯作者：
Li Y
影响因子：
7.3
作者：
Reiners KS;Dassler J;Coch C;Pogge von Strandmann E
通讯作者：
Pogge von Strandmann E
影响因子：
10.6
作者：
Lane RE;Korbie D;Hill MM;Trau M
通讯作者：
Trau M
影响因子：
11.5
作者：
Jin, Xiance;Chen, Yanfan;Xie, Congying
通讯作者：
Xie, Congying